BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16462868)

  • 21. The relationship between visual disability and visual scores in patients with retinitis pigmentosa.
    Sumi I; Matsumoto S; Okajima O; Shirato S
    Jpn J Ophthalmol; 2000; 44(1):82-7. PubMed ID: 10698030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Field "expansion" by use of binocular full-field reversed 1.3X telescopic spectacles: a case report.
    Mehr EB; Quillman RD
    Am J Optom Physiol Opt; 1979 Jul; 56(7):446-50. PubMed ID: 517637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between macular blood flow and central visual sensitivity in retinitis pigmentosa.
    Murakami Y; Ikeda Y; Akiyama M; Fujiwara K; Yoshida N; Nakatake S; Notomi S; Nabeshima T; Hisatomi T; Enaida H; Ishibashi T
    Acta Ophthalmol; 2015 Dec; 93(8):e644-8. PubMed ID: 25688697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mobility of people with retinitis pigmentosa as a function of vision and psychological variables.
    Haymes S; Guest D; Heyes A; Johnston A
    Optom Vis Sci; 1996 Oct; 73(10):621-37. PubMed ID: 8916133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wide-field fundus autofluorescence imaging of retinitis pigmentosa.
    Oishi A; Ogino K; Makiyama Y; Nakagawa S; Kurimoto M; Yoshimura N
    Ophthalmology; 2013 Sep; 120(9):1827-34. PubMed ID: 23631947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary visual cortical remapping in patients with inherited peripheral retinal degeneration.
    Ferreira S; Pereira AC; Quendera B; Reis A; Silva ED; Castelo-Branco M
    Neuroimage Clin; 2017; 13():428-438. PubMed ID: 28116235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinitis pigmentosa: visual function and multidisciplinary management.
    Herse P
    Clin Exp Optom; 2005 Sep; 88(5):335-50. PubMed ID: 16255692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of a Head-mounted Low Vision Device on Visual Function.
    Wittich W; Lorenzini MC; Markowitz SN; Tolentino M; Gartner SA; Goldstein JE; Dagnelie G
    Optom Vis Sci; 2018 Sep; 95(9):774-784. PubMed ID: 30153237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Visual rehabilitation in patients with retinitis pigmentosa].
    de Castro CT; Berezovsky A; de Castro DD; Salomão SR
    Arq Bras Oftalmol; 2006; 69(5):687-90. PubMed ID: 17187136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of spectacle mounted telescope systems by the visually impaired.
    Greene HA; Pekar J; Brilliant R; Freeman PB; Lewis HT; Siwoff R; Madden DJ; Westlund RE
    J Am Optom Assoc; 1993 Jul; 64(7):507-13. PubMed ID: 8376720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving visually guided action and perception through use of prisms.
    Eubank TF; Ooi TL
    Optometry; 2001 Apr; 72(4):217-27. PubMed ID: 11338446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional measures of mobility performance and retinitis pigmentosa.
    Geruschat DR; Turano KA; Stahl JW
    Optom Vis Sci; 1998 Jul; 75(7):525-37. PubMed ID: 9703042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual stabilization of posture in retinitis pigmentosa and in artificially restricted visual fields.
    Turano K; Herdman SJ; Dagnelie G
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):3004-10. PubMed ID: 8360031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
    Nakazawa M; Ohguro H; Takeuchi K; Miyagawa Y; Ito T; Metoki T
    Ophthalmologica; 2011; 225(2):120-6. PubMed ID: 20948238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VISUAL IMPAIRMENT IN RETINITIS PIGMENTOSA.
    Vezinaw CM; Fishman GA; McAnany JJ
    Retina; 2020 Aug; 40(8):1630-1633. PubMed ID: 31568063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.
    Peli E
    Optom Vis Sci; 2020 Oct; 97(10):833-846. PubMed ID: 33055514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function correlations in Retinitis Pigmentosa patients with partially preserved vision: a voxel-based morphometry study.
    Rita Machado A; Carvalho Pereira A; Ferreira F; Ferreira S; Quendera B; Silva E; Castelo-Branco M
    Sci Rep; 2017 Sep; 7(1):11411. PubMed ID: 28900214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.